Technology | December 09, 2014

Next generation quality assurance tool delivers expanded breast imaging metrics to provide critical insight for breast imaging workflow

Mammography systems, women's health, RSNA 2014, Volpara, breast density

Image courtesy of Volpara Solutions


December 9, 2014 — Volpara Solutions launched VolparaAnalytics version 1.2 at RSNA 2014. Volpara Solutions showcased the latest version of VolparaAnalytics and the rest of its suite of quantitative breast imaging tools, including VolparaDensity and VolparaDoseRT, which enable personalized measurements of volumetric density, patient-specific dose, breast compression and other factors designed to provide insight for breast imaging quality and workflow.

VolparaAnalytics, a centralized dashboard that presents key mammography metrics, works by automatically collating data from digital mammography and tomosynthesis units to enable cross-comparison of patient populations, mammography systems and operator performance. VolparaAnalytics is in use supporting quality assurance at breast imaging centers around the globe by monitoring critical elements of the breast imaging process and generating key metrics to help breast imaging centers identify and address potential issues early.

The new version of VolparaAnalytics, which will be available in early 2015, features an enhanced user interface and reporting tools, and delivers expanded breast imaging metrics to users including additional quality metrics, new temporal analysis tools, additional tools to analyse patient positioning and patient-dose and time between study acquisitions.

Volpara Solutions was recently recognized with the 2014 Technology Innovation Leadership Award in Breast Imaging from Frost & Sullivan based on independent analysis of the company’s technology excellence and visionary innovation. 

“One key new feature of the latest version of VolparaAnalytics is temporal analysis reporting, which allows users to view key breast imaging metrics such as compression force, applied pressure and mean glandular dose results over time to quickly identify inconsistencies that might have developed,” said Ralph Highnam, PhD., Volpara Solutions CEO and Chief Scientist.  “By providing objective volumetric context, this provides actionable insight to help breast centers improve patient care and productivity.”

VolparaAnalytics runs on top of VolparaDensity, a software tool in use at breast imaging centers worldwide to help radiologists objectively assess density from both digital mammography and tomosynthesis images and to determine which women would benefit from additional screening.  Highly correlated to breast MR assessments, VolparaDensity is a reliable tool that automatically generates an objective measurement of volumetric breast density correlated to the ACR (American College of Radiology) breast density categories.  To date, more than 4-million women have had their breast density analyzed using VolparaDensity. VolparaDoseRT provides a standardized measurement of patient-specific dose with consistent dose results across mammography systems from different manufacturers.

For more information: www.volparasolutions.com

 


Related Content

News | Breast Imaging

June 25, 2025 — QT Imaging Holdings, Inc., a medical device company engaged in research, development, and ...

Time June 25, 2025
arrow
News | Mammography

April 29, 2025 — iCAD, a global provider of clinically proven AI-powered cancer detection solutions, has announced a ...

Time April 29, 2025
arrow
News | Mammography

April 24, 2025 — GE HealthCare will feature its latest advancements in diagnostic accuracy and patient-centered breast ...

Time April 24, 2025
arrow
News | Artificial Intelligence

March 10, 2025 — Lunit, a provider of AI-powered solutions for cancer diagnostics and therapeutics, has published a ...

Time March 10, 2025
arrow
News | Artificial Intelligence

Feb. 19, 2025 — SimonMed Imaging and HeartLung Technologies have signed a strategic partnership to offer HeartLung's AI ...

Time March 04, 2025
arrow
News | Ultrasound Imaging

Jan. 28, 2025 — GE HealthCare recently announced it has received 510(k) clearance from the United States Food and Drug ...

Time January 29, 2025
arrow
News | Breast Imaging

Jan. 8, 2025 — ScreenPoint Medical has acquiredf Biomediq A/S, a research-based company focused on the research ...

Time January 10, 2025
arrow
News | Breast Imaging

Dec.11, 2024 — iCAD, Inc., a provider of clinically proven AI-powered cancer detection solutions, recently announced ...

Time December 18, 2024
arrow
News | Mammography

Dec. 5, 2024 — At RSNA 2024, Lunit and Volpara Health announced their unified vision, focusing on a comprehensive ...

Time December 05, 2024
arrow
News | Mammography

Nov. 26, 2024 — GE HealthCare has introduced the Pristina Via* mammography system designed to enhance the screening ...

Time December 02, 2024
arrow
Subscribe Now